Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening

• Antón L. Martínez ,

  Contributed equally to this work with: Antón L. Martínez, José Brea

  Roles Data curation, Investigation, Methodology, Writing – original draft

  Affiliation BioFarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain

  ⨯
• José Brea ,

  Contributed equally to this work with: Antón L. Martínez, José Brea

  Roles Conceptualization, Investigation, Supervision, Validation, Writing – original draft

  Affiliation BioFarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain

  ⨯
• Mateo Barro,

  Roles Investigation

  Affiliation BioFarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain

  ⨯
• Xavier Monroy,

  Roles Resources

  Affiliation WeLab Barcelona, Barcelona, Spain

  ⨯
• Manuel Merlos,

  Roles Writing – review & editing

  Affiliation WeLab Barcelona, Barcelona, Spain

  https://orcid.org/0000-0002-8423-3033

  ⨯
• Javier Burgueño ,

  Roles Funding acquisition, Supervision, Writing – review & editing

  * E-mail: jburgueno@welab.barcelona (JB); mabel.loza@usc.es (MIL)

  Affiliation WeLab Barcelona, Barcelona, Spain

  ⨯
• María Isabel Loza

  Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Validation, Writing – review & editing

  * E-mail: jburgueno@welab.barcelona (JB); mabel.loza@usc.es (MIL)

  Affiliation BioFarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain

  https://orcid.org/0000-0003-4730-0863

  ⨯